Pegfilgrastim biosimilar (Coherus BioSciences)

Product Name :
Pegfilgrastim biosimilar (Coherus BioSciences)

Search keywords :
OBI

drugId :
null

Target Vo:
Colony stimulating factor 3 receptor

Target Vo Short Name :
CSF3R

Moa_Name:
Colony stimulating factor 3 receptor agonists

First Approval Country :
EU

First Approval Date Filter:
2018

Origin Company_Name :
Coherus Biosciences Inc

Active Company_Name :
Coherus Biosciences Inc

Active Indication_Name:
Acute Radiation Syndrome

In Active Indication_Name:
Neutropenia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SQSTM1 / p62 Mouse mAb Biological Activity
Ustekinumab Immunology/Inflammation
SRD5A2 Antibody: SRD5A2 Antibody is an unconjugated, approximately 28 kDa, rabbit-derived, anti-SRD5A2 polyclonal antibody. SRD5A2 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in (predicted) human, mouse, rat, pig, horse background without labeling.

Author: Betaine hydrochloride

Related Posts